Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
We report a trend analysis of human intravenous pharmacokinetic data on a data set of 1352 drugs. The aim in building this data set and its detailed analysis was to provide, as in the previous case published in 2008, an extended, robust, and accurate resource that could be applied by drug metabolism, clinical pharmacology, and medicinal chemistry scientists to a variety of scaling approaches. All in vivo data were obtained or derived from original references, either through the literature or regulatory agency reports, exclusively from studies utilizing intravenous administration. Plasma protein binding data were collected from other available sources to supplement these pharmacokinetic data. These parameters were analyzed concurrently with a range of physicochemical properties, and resultant trends and patterns within the data are presented. In addition, the date of first disclosure of each molecule was reported and the potential “temporal” impact on data trends was analyzed. The findings reported here are consistent with earlier described trends between pharmacokinetic behavior and physicochemical properties. Furthermore, the availability of a large data set of pharmacokinetic data in humans will be important to further pursue analyses of physicochemical properties, trends, and modeling efforts and should propel our deeper understanding (especially in terms of clearance) of the absorption, distribution, metabolism, and excretion behavior of drug compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 4×
“This is similar to the development of several notable guidelines, such as the “ rule of 5 ” (Lipinski, 1997) or the rotatable bond limits described by Veber et al. (2002) stemming from similar observations, although the aim of both reports was to derive guidelines toward improved oral absorption.”
BackgroundResultInfluentialStructural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941 · cited 1×
“…43 m M or 1.8 g/l; Davies and Morris, 1993), with the former mostly associated with binding anionic drugs and the latter, primarily but not exclusively, associated with binding cationic drugs (Meijer and Van der Sluijs, 1987; Israili and Dayton, 2001; Ghuman et al., 2005; Kremer et al., 1988).”
BackgroundInfluentialThe Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Self-citationWard, K. W., & Smith, B. R. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.603 · Cited by 212
Caldwell, G. W., Masucci, J. A., Yan, Z., & Hageman, W. (2004) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190588 · Cited by 148 · cited 1×
“…reports, of which we cite a few examples, have focused on scaling techniques (i.e., approaches and techniques that use animal pharmacokinetic data) (Caldwell et al., 2004; Ward and Smith, 2004a,b; Jolivette and Ward, 2005; Evans et al., 2006; Mahmood et al., 2006; Martinez et al., 2006; Tang and…”
BackgroundLombardo, F., Waters, N. J., Argikar, U. A., Dennehy, M. K., Zhan, J., Gunduz, M., Harriman, S. P., Berellini, G., Liric Rajlic, I., & Obach, R. S. (2013) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012440282 · Cited by 106
Self-citationTang, H., & Mayersohn, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20481 · Cited by 89 · cited 1×
“…data) (Caldwell et al., 2004; Ward and Smith, 2004a,b; Jolivette and Ward, 2005; Evans et al., 2006; Mahmood et al., 2006; Martinez et al., 2006; Tang and Mayersohn, 2006; Fagerholm, 2007; McGinnity et al., 2007; Lombardo et al., 2013a,b) as well as in vitro data (Obach et al., 1997; Lombardo…”
BackgroundEvans, C. A., Jolivette, L. J., Nagilla, R., & Ward, K. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006619 · Cited by 32
Cited by
Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling
Chou, W.-C., & Lin, Z. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfac101 · Cited by 190
DrugCentral 2021 supports drug discovery and repositioning
Avram, S., Bologa, C. G., Holmes, J., Bocci, G., Wilson, T. B., Nguyen, D.-T., Curpan, R., Halip, L., Bora, A., Yang, J. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa997 · Cited by 189
Davies, M., Jones, R. D. O., Grime, K., Jansson-Löfmark, R., Fretland, A. J., Winiwarter, S., Morgan, P., & McGinnity, D. F. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.03.004 · Cited by 123
Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies
Kanebratt, K. P., Janefeldt, A., Vilén, L., Vildhede, A., Samuelsson, K., Milton, L., Björkbom, A., Persson, M., Leandersson, C., Andersson, T. B., et al. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.043 · Cited by 66
Sakolish, C., Tsai, H.-H. D., Lin, H.-C., Bajaj, P., Villenave, R., Ferguson, S. S., Stanko, J. P., Becker, R. A., Hewitt, P., Chiu, W. A., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13030563 · Cited by 11
“Values for f ub,plasma for each chemical were primarily obtained from previous publications [43] or sourced from the CompTox Dashboard (https://comptox.epa.gov/dashboard/, accessed on 17 February 2025) (Table S2).”
Named entity recognition of pharmacokinetic parameters in the scientific literature
Gonzalez Hernandez, F., Nguyen, Q., Smith, V. C., Cordero, J. A., Ballester, M. R., Duran, M., Solé, A., Chotsiri, P., Wattanakul, T., Mundin, G., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-73338-3 · Cited by 8
“Consequently, researchers must search and curate PK estimates from scientific literature before pre-clinical predictions can be made [Grzegorzewski et al., 2021, Lombardo et al., 2018].”
Background
Metadata
- Authors
- Lombardo, F., Berellini, G., & Obach, R. S.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 46
- Issue
- 11
- Pages
- 1466-1477
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W4239082087
- Cited by
- 174
- References
- 8
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.